U.S. Healthcare Reimbursement Guidance for Foreign Life Sciences Companies

In this episode, Mike Burke, AGG Corporate partner and co-chair of the firm’s International practice, is joined by Andrew Tsui, AGG Healthcare Litigation partner, to explore the intricacies of reimbursement in the U.S. healthcare system. Mike and Andrew discuss challenges foreign life sciences companies face related to Medicare and Medicaid reimbursement, the regulatory hurdles involved, and common pitfalls to avoid. They also highlight the importance of understanding compliance requirements, enforcement mechanisms, and the role of federal agencies in shaping payment determinations.